Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
André J. Scheen. (2017) Pharmacotherapy of ‘treatment resistant’ type 2 diabetes. Expert Opinion on Pharmacotherapy 18:5, pages 503-515.
Read now
Read now
Vojtech Hainer. (2016) Beta3-adrenoreceptor agonist mirabegron – a potential antiobesity drug?. Expert Opinion on Pharmacotherapy 17:16, pages 2125-2127.
Read now
Read now
Velimir Altabas & Vanja Zjačić-Rotkvić. (2015) Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy. ImmunoTargets and Therapy 4, pages 123-130.
Read now
Read now
Articles from other publishers (13)
Velislava Todorova, Martina S. Savova, Stanislava Ivanova, Kalin Ivanov & Milen I. Georgiev. (2023) Anti-Adipogenic Activity of Rhaponticum carthamoides and Its Secondary Metabolites. Nutrients 15:13, pages 3061.
Crossref
Crossref
Xueling Liu, Tongshun An, Zhiping Yin & Wenzhou Zhang. (2022)
Palladium‐Catalyzed Reductive Double Carbonylation of Nitroarenes with Aryl Halides Using Mo(CO)
6
as a Reductant and Carbonyl Source
. Chemistry – A European Journal 29:2.
Crossref
Crossref
Tongshun An, Chenwei Liu, Yanzhao Yin, Xiao-Feng Wu & Zhiping Yin. (2022)
Palladium-Catalyzed Denitrogenative Carbonylation of Benzotriazoles with Cr(CO)
6
as the Carbonyl Source
. Organometallics 41:13, pages 1731-1737.
Crossref
Crossref
İrfan Koca, Volkan Kamaci, Ceylan Özsoy, Yusuf Sert, İbrahim Kani, Lütfi Tutar & Yusuf Tutar. (2022) Pyrazolyl‐Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer. ChemistrySelect 7:19.
Crossref
Crossref
Yanmei Wang, Qianxian Wu, Qian Zhou, Yuyu Chen, Xingxing Lei, Yiding Chen & Qiu Chen. (2022) Circulating acyl and des-acyl ghrelin levels in obese adults: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Xihua Jia, Manglin Xu, Aigang Yang, Yan Zhao, Dong Liu, Jian Huang, Peter Proksch & Wenhan Lin. (2019) Reducing Effect of Farnesylquinone on Lipid Mass in C. elegans by Modulating Lipid Metabolism. Marine Drugs 17:6, pages 336.
Crossref
Crossref
Sae-Rom Yoo, Soo-Jin Jeong, Mee-young Lee, Hyeun-Kyoo Shin, Chang-Seob Seo & Hyekyung Ha. (2018) Single Oral Acute Toxicity of Banhasasim-Tang and Its Antiobesity Effect on Diet-Induced Obese Mice and 3T3-L1 Adipocytes. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-9.
Crossref
Crossref
Donald E. Greydanus, Marisha Agana, Manmohan K. Kamboj, Saad Shebrain, Neelkamal Soares, Ransome Eke & Dilip R. Patel. (2018) Pediatric obesity: Current concepts. Disease-a-Month 64:4, pages 98-156.
Crossref
Crossref
Vicky Ping Chen, Yang Gao, Liyi Geng & Stephen Brimijoin. (2017) Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling. Proceedings of the National Academy of Sciences 114:41, pages 10960-10965.
Crossref
Crossref
Maite Solas, Fermin I. Milagro, Diego Martínez-Urbistondo, Maria J. Ramirez & J. Alfredo Martínez. (2016) Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches. Trends in Pharmacological Sciences 37:7, pages 575-593.
Crossref
Crossref
Yue Chen. (2016) Regulation of food intake and the development of anti-obesity drugs. Drug Discoveries & Therapeutics 10:2, pages 62-73.
Crossref
Crossref
Nina Schweinfurth, Marc Walter, Stefan Borgwardt & Undine E. Lang. 2016. Obesity. Obesity
235
244
.
Zhu-Sheng Chu, Zhi-Ling Yu, Si-Yuan Pan, Zhan-Hong Jia, Xiao-Yan Wang, Yi Zhang, Pei-Li Zhu, Xiu-Juan Wang & Kam-Ming Ko. (2015) A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice. Lipids in Health and Disease 14:1.
Crossref
Crossref